In a series of 25 patients with suspected pneumonia related to the acquired immune deficiency syndrome (AIDS) the first 12 underwent routine fibreoptic bronchoscopy and bronchoalveolar savage with or without transbronchial biopsy before treatment. Eight were found to have Pneumocystis carinii pneumonia and had typical clinical presentations with a prolonged history of symptoms, including a dry cough, and bilateral diffuse alveolar or interstitial shadowing in chest radiographs.
Introduction
It has been suggested that all patients with suspected pneumonia related to the acquired immune deficiency syndrome (AIDS) should be diagnosed with fibreoptic bronchoscopy and bronchoalveolar savage with or without transbronchial biopsy before treatment.'Ẁ e describe the clinical features, treatment, and outcome in 12 patients managed in this way and 13 subsequent patients treated empirically without initial bronchoscopy.
Patients and methods
All patients suspected of having AIDS related pneumonia fulfilled the following criteria: (a) they were homosexuals and therefore in a high risk group for acquiring AIDS; (b) they possessed antibody to human immunodeficiency virus (HIV); (c) they had symptoms of lower respiratory tract infection; (d) they had abnormal chest radiographs; and (e) they had resting hypoxaemia in air or an alveolar-arterial oxygen gradient >20 mm Hg.
The first 12 patients (the bronchoscopy group) underwent fibreoptic bronchoscopy and bronchoalveolar lavage with or without transbronchial biopsy at or soon after presentation. Bronchoalveolar after routine sputum and blood investigations had been performed. Those suspected of having P cannii pneumonia from the clinical features listed above were given high doses of intravenous co-trimoxazole (trimethoprim 20 mg/kg/day, sulphamethoxazole 100 mg/kg/day in divided doses). If there was no clinical improvement after five days of treatment, or deterioration at any stage, fibreoptic bronchoscopy and bronchoalveolar lavage with or without transbronchial biopsy were performed. Patients suspected of having other pneumonias underwent fibreoptic bronchoscopy and bronchoalveolar lavage with or without transbronchial biopsy if routine sputum, blood, and serological investigations yielded no diagnosis (fig 1) . We also examined sputum, induced by nebulising 4 ml 2 7% saline via a facemask, for pathogens including P cannii and measured pneumocystis antigen and antibody in serum from our later patients. 
Results
Clinical features and investigations-The table shows the clinical features of the two groups of patients. Two patients in each group had Kaposi's sarcoma. More patients in the clinical group (seven patients) were known to have AIDS or to have suffered from previous pneumonic episodes than in the bronchoscopy group (three patients). Six of the 11 patients with clinically suspected P carnnii pneumonia had no respiratory crackles at presentation. All patients with P canrnii pneumonia in the bronchoscopy group had bilateral diffuse alveolar or interstitial shadowing in chest radiographs. Nine of 11 patients with suspected P carinii pneumonia in the clinical group also had bilateral diffuse shadowing. The other two had normal chest radiographs initially but developed diffuse shadowing after a short period of observation. In contrast, none of the patients with bacterial pneumonias had diffuse shadowing. All had focal abnormalities; these were bilateral in one patient in the bronchoscopy group. Diagnosis in the bronchoscopy group- Figure 2 shows that eight of the 12 patients were found to have P carinii pneumonia, six by transbronchial biopsy alone, one by bronchoalveolar lavage alone, and one by fine needle aspiration biopsy after bronchoalveolar lavage and transbronchial biopsy had yielded negative results. In three of the remaining four patients bacteria (Pneumococcus in two and Pseudomonas aeruginosa in one) were isolated from both bronchoalveolar lavage and transbronchial biopsy specimens and were therefore thought to be pathogenic. Oropharyngeal organisms subsequently isolated by bronchoalveolar lavage alone were deemed to be contaminants. In the one remaining patient (our first) no firm diagnosis was made. Despite broad spectrum antibiotic cover, including antipneumocystis treatment, he died in the intensive care unit. Diagnosis in the clinical group- Figure 3 shows that probable P carinti pneumonia was diagnosed clinically in 11 of the 13 patients and that they were treated with high doses of co-trimoxazole. Eight improved, and two of the three who failed to respond to co-trimoxazole underwent fibreoptic bronchoscopy. P carinii pneumonia was confirmed in one, who then responded to further co-trimoxazole. The other had negative results from fibreoptic bronchoscopy, bronchoalveolar lavage, and transbronchial biopsy and died from respiratory failure; needle necropsy of the lung failed to yield a diagnosis. The third patient was moribund on admission and did not undergo fibreoptic bronchoscopy; needle necropsy confirmed the clinical diagnosis of P carinii pneumonia. Two of the 13 patients had suspected bacterial or other pneumonia. Haemophilus influenzae was isolated from the sputum of one, who improved with appropriate treatment. In the other all initial investigations yielded negative results, but Mycobacterium tuberculosis was isolated by both bronchoalveolar lavage and transbronchial biopsy.
Treatment-All 19 patients with proved or suspected P carinii pneumonia were treated with high doses of co-trimoxazole. Side effects were similar in number and type in both groups and included a rash (three patients), thrombocytopenia (four), and nausea and vomiting (three). The drug was stopped in five patients. Pentamidine was given to seven of the 19 patients (six intramuscularly and one intravenously). Five were changed to pentamidine from co-trimoxazole and two were given both drugs concurrently. A decrease in renal function occurred in five patients; in one treatment had to be stopped. Survival-Early survival-that is, eight weeks from diagnosis ofP carinii pneumonia-was six out of eight patients in the bronchoscopy group and nine out of 11 in the clinical group. Only one patient with P carinii pneumonia in the bronchoscopy group was still alive at 40 weeks. In the clinical group seven patients survived for 16 to 40 weeks.
Discussion
Transbronchial biopsy is currently important in the diagnosis of P carinii pneumonia, being capable of diagnosing up to 93% ofcases when used alone and e'ven more when combined with other procedures such as bronchoalveolar lavage, touch imprints, and bronchial brushings.3 A recent study that emphasised the importance of close liaison with a specifically skilled cytopathology department suggested that bronchoalveolar lavage alone may be diagnostic in 98% of cases7; this contrasts with figures of790/o to 85% in earlier studies.23 In the bronchoscopy group we found that transbronchial biopsy had a higher diagnostic rate than bronchoalveolar lavage. We did not obtain bronchial brushings routinely.
Our decision to treat 13 patients with suspected AIDS related pneumonia on clinical grounds alone and to perform fibreoptic bronchoscopy, bronchoalveolar lavage, and transbronchial biopsy only in those who failed to respond or who deteriorated arose from many considerations.
'Firstly, large studies in the United States have shown that 66% to 85% of all AIDS pneumonia is due to P carinii pneumoma. In those patients whose symptoms suggested P carinii pneumonia we therefore questioned whether an invasive procedure that is not without definite risk to the patient8 and theoretical risk to the operator was justified.
Secondly, the potential number of patients with AIDS and pulmonary complications is increasing. In 1988 alone there may be 2500 patients with AIDS in the United Kingdom, ofwhom 750 may have P carinii pneumonia9 (Communicable Disease Surveillance Centre). Bronchoscopy for every case may be unrealistic.
Thirdly, immediate treatment on clinical diagnosis avoids any delay incurred by waiting for fibreoptic bronchoscopy and the results of bronchoalveolar lavage with or without transbronchial biopsy. Interestingly, any subsequent isolation ofP carinii does not seem to be affected by the duration of treatment with cotrimoxazole.3 4 10 Fourthly, staff anxiety about possible infection with HIV was high. Despite reassuring results of studies of nosocomial and needlestick exposure"'3 at least one case of seroconversion has been reported in the United Kingdom. 14 Fifthly, non-lifesaving surgery and postmortem procedures in patients who are HIV positive have been curtailed or are unavailable. ' One argument for routine fibreoptic bronchoscopy is to confirm a diagnosis of AIDS. The identification of Str pneumoniae or M tuberculosis by fibreoptic bronchoscopy, however, does not at present fulfil the criteria of the Center for Disease Control for the diagnosis of AIDS, though these, pneumonias occur far more commonly in patients with AIDS.3'"8 Counselling patients with high risk factors for AIDS who show evidence of HIV infection and P carinii pneumonia has not been problematic in our experience.
Other non-invasive investigations may be ofuse in diagnosis. The role of pneumocystis serology in pneumonia related to AIDS is being evaluated. Induced sputum examination for pneumocystis has been useful in two recent studies."92"
Despite the problems discussed our results suggest that a'clinical approach to suspected pneumonia related to AIDS-may be useful. We conclude that, in high risk patients-with appropriate clinical features of P carinni pneumnonia, starting treatment with high doses of co-trimoxazole is justified. Bronchoscopy should be performed on those who fail to respond. Focal radiological disease is unlikely to be P carinii pneumonia and should be investigated -by early bronchoscopy if initial non-invasive investigations are unhelpful.
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